failure to respond or late response
on 09 Mar 2023
Last Applicant/ Owned by
873 Rue Saint-Jean, suite 200
Quebec (Quebec)
CA
G1R1R2
Serial Number
88813300 filed on 27th Feb 2020
Registration Number
N/A
Correspondent Address
Peter Kunin
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"IMMUNOTHERAPY"
(Based on 44(d) Priority Application) (Based on Intent to Use) Development of pharmaceutical preparations and medicines; drug discovery services; software as a service (SAAS) services featuring artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in the field of providing pharmaceutical products in orRead More
(Based on 44(d) Priority Application) (Based on Intent to Use) Medical services, namely, vaccinal pharmacologic treatment of autoimmune diseases such as psoriasis, Crohn's disease, rheumatoid arthritis, cancer, infectious diseases and allergies; health care services, namely, desensitization treatments for allergy; medical services, namely, immunotherapy in the fields of cancer, autoimmune, infectious disease and orphan diseases conditions in humans and veterinary applications; medical treatment of allergies, cancer, and auto-immune diseases destined to generate, in response to its administration in patients, the production of the patient's own antibodies
(Based on 44(d) Priority Application) (Based on Intent to Use) Development of pharmaceutical preparations and medicines; drug discovery services; software as a service (SAAS) services featuring artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in the field of providing pharmaceutical products in order to create as many therapeutic different therapeutic agents deemed in the pharmaceutical industry and nanoparticles; platform as a service (PAAS) services featuring artificial intelligence software platforms for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining for use in the field of pharmacological and pharmaceutical products in order to create as many therapeutic different therapeutic agents deemed in the pharmaceutical industry and nanoparticles; platform as a service (PAAS) services featuring computer software platforms for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining for use in the field of pharmacological and pharmaceutical applications that is an immunomodulatory vector on which biologic targets determine the pertinence and use of these pharmacological agents
(Based on 44(d) Priority Application) (Based on Intent to Use) Protein arrays for medical diagnosis purposes; proteins arrays for therapeutic use for treating cancer, allergies, autoimmune disease, infection disease, and inflammatory disease; biopharmaceuticals for treatment of cancer, allergies, autoimmune disease, infection disease; pharmaceutical preparations for use in the treatment of allergy, cancer, infectious diseases and immune diseases; pharmacological preparations able to effect immunotherapy with specific attributes of potency and safety
(Based on 44(d) Priority Application) (Based on Intent to Use) Chemicals for use in the manufacture of pharmaceuticals; proteins for immunoassay for detection, for diagnostic purposes, for therapeutic purposes and for treatment of cancer, allergies, autoimmune disease, infection diseases; all of the foregoing expressly excluding biologically-derived particles that can be fluorescently-labeled for scientific research purposes
No 88813300
No Service Mark
No 13615134UST1
Yes
Yes
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 09th Mar 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 09th Mar 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 17th Jan 2023 | ASSIGNED TO EXAMINER |
| 25th Aug 2022 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| 25th Aug 2022 | SUSPENSION INQUIRY WRITTEN |
| 25th Aug 2022 | INQUIRY TO SUSPENSION E-MAILED |
| 25th Aug 2022 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| 24th Feb 2022 | SUSPENSION LETTER WRITTEN |
| 24th Feb 2022 | LETTER OF SUSPENSION E-MAILED |
| 24th Feb 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
